[1] CALLE A, BLÜMEL JE, CHEDRAUI P, et al. Severe menopausal symptoms linked to cognitive impairment: an exploratory study. Menopause. 2024;31(11):959-965.
[2] TANG F, CHI I, DONG X. Sex Differences in the Prevalence and Incidence of Cognitive Impairment: Does Immigration Matter? J Am Geriatr Soc. 2019;67(S3):S513-S518.
[3] CONLEY AC, ALBERT KM, MCDONALD BC, et al. Estradiol treatment in young postmenopausal women with self-reported cognitive complaints: Effects on cholinergic-mediated cognitive performance. Hum Psychopharmacol. 2022; 37(5):e2838.
[4] 贺舒凝,张佳豪,杨若男,等.我国45岁及以上人群认知功能障碍的空间分布及其影响因素[J].南方医科大学学报,2023,43(4):611-619.
[5] STICKEL AM, TARRAF W, KUWAYAMA S, et al. Connections between reproductive health and cognitive aging among women enrolled in the HCHS/SOL and SOL-INCA. Alzheimers Dement. 2024;20(3):1944-1957.
[6] BLÜMEL JE, ARTEAGA E, VALLEJO MS, et al. Association of bilateral oophorectomy and menopause hormone therapy with mild cognitive impairment: the REDLINC X study. Climacteric. 2022;25(2):195-202.
[7] SOCHOCKA M, KARSKA J, PSZCZOLOWSKA M, et al. Cognitive Decline in Early and Premature Menopause. Int J Mol Sci. 2023;24(7):6566.
[8] BUTLER T, TEY S, GALVIN JE, et al. Endocrine Dyscrasia in the Etiology and Therapy of Alzheimer’s Disease. J Alzheimers Dis. 2024; 101(3):705-713.
[9] BODDETI U, POLAVARAPU H, PATEL S, et al. Current Status of Awake Spine Surgery: A Bibliometric Analysis. World Neurosurg. 2024;187:194-201.e2.
[10] WAN Y, SHEN J, OUYANG J, et al. Bibliometric and visual analysis of neutrophil extracellular traps from 2004 to 2022. Front Immunol. 2022; 13:1025861.
[11] ZHAO L, ZHANG G, YANG J, et al. Knowledge mapping and emerging trends in cognitive impairment associated with chronic pain: A 2000-2024 bibliometric study. Brain Res Bull. 2025;220:111175.
[12] MA Y, KRAEMER KM, LYU J, et al. Randomized Controlled Trials of Mindfulness and Acceptance-Based Interventions Over the Past Two Decades: A Bibliometric Analysis. J Altern Complement Med. 2021;27(11):930-939.
[13] JIN L, WU L, ZHANG J, et al. Quantitative analysis of literature on diagnostic biomarkers of Schizophrenia: revealing research hotspots and future prospects. BMC Psychiatry. 2025;25(1):186.
[14] LI D, WU M. Potential value and research frontiers of virus in neuroinflammation: a bibliometric and visualized analysis. Front Immunol. 2024;15: 1390149.
[15] ARIA M, CUCCURULLO C. bibliometrix: An R-tool for comprehensive science mapping analysis. J Informetr. 2017;11(4):959-975.
[16] SABE M, PILLINGER T, KAISER S, et al. Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends. Neurosci Biobehav Rev. 2022;136:104608.
[17] PALOMINO-LEYVA C, RIVERA-RECUENCO J, FERNANDEZ-GIUSTI A, et al. Bibliometric analysis of the worldwide scientific production on COVID-19 infection and cerebrovascular disease. Ann Card Anaesth. 2023;26(2):197-203.
[18] HONG T, FENG X, TONG W, et al. Bibliometric analysis of research on the trends in autophagy. PeerJ. 2019;7:e7103.
[19] GUO M, WU Y, GROSS AL, et al. Age at menopause and cognitive function and decline among middle-aged and older women in the China Health and Retirement Longitudinal Study, 2011-2018. Alzheimers Dement. 2025;21(2):e14580.
[20] OMEROVIC E, PETRIE M, REDFORS B, et al. Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9-Pragmatic Research and Innovation through Multinational Experimentation. Trials. 2024; 25(1):80.
[21] CAO C, LI S, ZHOU G, et al. Global trends in COVID-19 Alzheimer’s related research: a bibliometric analysis. Front Neurol. 2023;14: 1193768.
[22] ROGIC S, POIRIER-MORENCY G, HIETER P, et al. Global partnerships in rare disease research. Dis Model Mech. 2025;18(7):dmm052401.
[23] KAUR M, KAUR M. Cognitive performance of women at various stages of reproductive aging and associated risk factors. Climacteric. 2022;25(3):278-285.
[24] BORTZ J, KLATT KC, WALLACE TC. Perspective: Estrogen and the Risk of Cognitive Decline: A Missing Choline(rgic) Link. Adv Nutr. 2022;13(2): 376-387.
[25] HUANG W, JIANG S, GENG L, et al. Correlation between menopausal symptoms and everyday cognition in Chinese (peri)menopausal women. Gynecol Endocrinol. 2021;37(7):655-659.
[26] RADAGHDAM S, KARAMAD V, NOURAZARIAN A, et al. Molecular mechanisms of sex hormones in the development and progression of Alzheimer’s disease. Neurosci Lett. 2021;764:136221.
[27] THAN S, MORAN C, BEARE R, et al. Cognitive trajectories during the menopausal transition. Front Dement. 2023;2:1098693.
[28] TICKERHOOF M, CHAM H, OULDIBBAT L, et al. Postmortem tissue biomarkers of menopausal transition. Preprint. bioRxiv. 2024; 2024.06.20.599941.
[29] HAN S, LIU D, TAN C, et al. Male- and female-specific reproductive risk factors across the lifespan for dementia or cognitive decline: a systematic review and meta-analysis. BMC Med. 2023;21(1):457.
[30] GONZÁLEZ-BURGOS I, VELÁZQUEZ-ZAMORA DA, GONZÁLEZ-TAPIA D. Estradiol-mediated modulation of memory and of the underlying dendritic spine plasticity through the life span. Histol Histopathol. 2024;39(4):411-423.
[31] LI M, ZHANG J, SHI Y, et al. The radiomics features of the temporal lobe region related to menopause based on MR-T2WI can be used as potential biomarkers for AD. Cereb Cortex. 2023;33(14):9067-9078.
[32] ZHAO J, JIAO Y, WANG H, et al. Radiomic features of the hippocampal based on magnetic resonance imaging in the menopausal mouse model linked to neuronal damage and cognitive deficits. Brain Imaging Behav. 2024;18(2):368-377.
[33] LEE JK, RAGHAVAN S, CHRISTENSON LR, et al. Longitudinal associations of reproductive factors and exogeneous estrogens with neuroimaging biomarkers of Alzheimer’s disease and cerebrovascular disease. Alzheimers Dement. 2024;20(7):4613-4624.
[34] WANG Y, THERRIAULT J, TISSOT C, et al. Hormone therapy is associated with lower Alzheimer’s disease tau biomarkers in post-menopausal females -evidence from two independent cohorts. Alzheimers Res Ther. 2024;16(1):162.
[35] MOIR ME, CORKERY AT, SENESE KA, et al. Age at natural menopause impacts cerebrovascular reactivity and brain structure. Am J Physiol Regul Integr Comp Physiol. 2023;324(2):R207-R215.
[36] JETT S, SCHELBAUM E, JANG G, et al. Ovarian steroid hormones: A long overlooked but critical contributor to brain aging and Alzheimer’s disease. Front Aging Neurosci. 2022;14:948219.
[37] NICOTRA R, LUTZ C, MESSAL HA, et al. Rat Models of Hormone Receptor-Positive Breast Cancer. J Mammary Gland Biol Neoplasia. 2024;29(1):12.
[38] RUPEĆ Z, TRUBALSKI M, ZULFIQUAR Z, et al. Hormonal influence on osteoporosis. Wiad Lek. 2025;78(3):531-538.
[39] NAGDA AL, DATAR MC, NAPHADE NM, et al. A Cross-sectional Assessment of Depression, Anxiety, and Cognition in Perimenopausal and Menopausal Women. J Midlife Health. 2023;14(2):117-122.
[40] SCHAEDEL Z, HOLLOWAY D, BRUCE D, et al. Management of sleep disorders in the menopausal transition. Post Reprod Health. 2021;27(4):209-214.
[41] MA J, CHEN YH, CHIANG CP, et al. Hormone replacement therapy did not increase risk of melanoma in Chinese female with menopausal and postmenopausal disorders: A population-based retrospective cohort study in Taiwan. J Dermatol. 2023;50(9):1162-1169.
[42] JAFF NG, CROWTHER NJ. The Association of Reproductive Aging with Cognitive Function in Sub-Saharan African Women. Methods Mol Biol. 2022;2343:71-91.
[43] VIDYANTI AN, RAHMAWATI F, RAHMAN RH, et al. Lifestyle interventions for dementia risk reduction: A review on the role of physical activity and diet in Western and Asian Countries. J Prev Alzheimers Dis. 2025;12(2):100028.
[44] WANG J, RANG Y, LIU C. Effects of Caloric Restriction and Intermittent Fasting and Their Combined Exercise on Cognitive Functioning: A Review. Curr Nutr Rep. 2024;13(4):691-700.
[45] OBERLIN LE, JAYWANT A, WOLFF A, et al. Strategies to Promote Cognitive Health in Aging: Recent Evidence and Innovations. Curr Psychiatry Rep. 2022;24(9):441-450.
[46] XU X, CHEW KA, WONG ZX, et al. The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER): Study Design and Protocol. J Prev Alzheimers Dis. 2022;9(1):40-48.
[47] CALSOLARO V, BOTTARI M, COPPINI G, et al. Endocrine dysfunction and cognitive impairment. Minerva Endocrinol (Torino). 2021; 46(3):335-349.
[48] GHOSSON A, SOUFAN F, KADDOURA H, et al. Understanding the Intersection Between Hormonal Dynamics and Brain Plasticity in Alzheimer’s Disease: A Narrative Review for Implementing New Therapeutic Strategies. Health Sci Rep. 2025;8(7):e70975.
[49] DEBNATH C, GURIA S, GUHA D, et al. A Novel BOND-KNN Algorithm to Predict Breast Cancer Survival using Multi-modal Features. Annu Int Conf IEEE Eng Med Biol Soc. 2024;2024:1-4.
[50] CHEN M, ZHAO G, PENG L. Transcranial Magnetic Stimulation Applications in the Study of Executive Functions: A Review. Brain Behav. 2024;14(11):e70099.
|